Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant. - Lewis JH; Andrade RJ; Larrey D; Horsmans Y; Anderson RA; Trajanovic M; Groettrup-Wolfers E; Zuurman L (Drug safety, 2026)